PRESS RELEASE

<< Back

Lexington Pharmaceuticals names Bert Liang, MD MBA as President and CEO. Dr. Liang was formerly Vice President of New Ventures, at Biogen Idec.

April 1, 2005

Lexington Pharmaceuticals names Bert Liang, MD MBA as President and CEO. Dr. Liang was formerly Vice President of New Ventures, at Biogen Idec. He previously served as Site Head for Development, San Diego for Biogen Idec, as well as Vice President, Hematology/Oncology. Dr. Liang serves on the Boards of TRF Pharma, Actokine and Sirrius Medicine, and the Scientific Advisory Board of Amphora Corporation. He is a venture partner with Paramount Biosciences.

ABOUT TRACON Pharmaceuticals:
TRACON Pharmaceuticals is a private development stage biopharmaceutical firm formed in January 2005, located in San Diego, CA. TRACON is focused on developing and commercializing effective, novel, targeted therapies for patients with cancer.